<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0053">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Lobo-Galo</surname>
    <given-names>N.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Terrazas-López</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Martínez-Martínez</surname>
    <given-names>A.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Díaz-Sánchez</surname>
    <given-names>Á. G.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication</article-title>. 
  <source>
   <italic>Journal of Biomolecular Structure and Dynamics</italic>
  </source>, 
  <fpage>1</fpage>–
  <lpage>12</lpage>. 
  <pub-id pub-id-type="doi">10.1080/07391102.2020.1764393</pub-id>
 </mixed-citation>
</ref>
